Partnerships

 

 

This conference provides a space for those directly involved in cementing the details of partnerships with big pharma, biotechs, academia and non-profit organisations to share their case studies and gain insight into best practice. If you are looking for potential partnerships and collaborations, makes sure you participate in this conference to meet new vaccine biotechs showcasing their technology and pipeline.

 

2018 AGENDA​

 

Partnerships, Wednesday 4 April 2018

Partnerships
09:00

Chair’s opening remarks

Industry Insights & Biotech Showcases

New technology from the most promising biotechs and institutions

Viral Vectors & Novel Platforms

Heinz Feldmann
Partnerships
09:40

Technology showcase 1

Vesicular stomatitis virus vectors – A promising vaccine platform
 
Dr Sally Mossman
Partnerships
09:55

Technology showcase 2

Chimpanzee adenovirus vector vaccine technology
 
Prof James Moon
Partnerships
10:10

Technology showcase 3

Nanodisc technology for personalized cancer vaccination
David Hipkiss
Partnerships
10:25

Technology showcase 4

ImplaVaxTM – Unique needle free solid dose vaccine platform delivering enhanced immunogenicity with ultimate convenience and no cold chain
 
10:40

Networking coffee break

Dr Dan Stinchcomb
Partnerships
11:40

Technology showcase 5

Novel nanoparticle formulations for delivery of protein or RNA vaccines
 
Dr Robin Löving
Partnerships
11:55

Technology showcase 6: Salipro nano-membrane particles - A platform for antigen stabilization and vaccine development

Dr Pierre Charneau
Partnerships
12:10

Technology showcase 7: Lentiviral vectors as a novel platform for T-cells vaccines

Dr Pierre Charneau, Head, Theravectys
Stephen Nagler
Partnerships
12:25

Investor panel: Hear from different VCs to better understand what they are looking for before they invest

More VCs to be announced shortly
1:10

Networking Lunch & Poster Session

Funding Your Research & Expanding Your Range of Partnerships

Timothy Cooke
Partnerships
2:40

The formation of new companies developing infectious disease vaccines

 
  • The impact of the current vaccine industry ecosystem on funding for vaccine start-ups
  • Looking beyond venture capital for early stage funding
B.T. Slingsby
Partnerships
3:10

Innovative mechanisms in funding vaccine technology: A PPP model for international partnerships that bring Japanese innovation, investment and leadership

  • How will current investments plan contribute to IDs, NTDs and vaccine development?
  • The importance of cross collaborations
Dr Jorge Kalil
Partnerships
3:40

The role of emerging markets in the global supply and demand for vaccines: Perspectives from Brazil

  • Paving the way for a Dengue vaccine in Brazil
  • Soliciting support for sound scientific endeavors
  • Developing the framework for their realization, and reaching out for international partners
4:10

Networking coffee break

Dr Steven Reed
Partnerships
4:40

Partnerships for global health: Redefining areas of the vaccine business that don’t attract commercial interest and revenue

  • How new international partnerships in different markets can help you find new alternative investments
  • Going beyond science: Moving to where the people are to redefine the vaccine business model
Dr Peter Dull
Partnerships
5:10

A double perspective from both sides: How to foster vaccine partnerships

  • Lesson learned in global access agreements
  • Catalytic funding
Partner to be announced
Nima Farzan
Partnerships
5:40

How to fund and develop vaccines for overlooked diseases? Insights on how a biotech should approach big organisations for a partnership deal

  • How to position yourself to the different pharma companies and investors to gain maximal funding and options
  • Deal structure and alliance management
6:10

Chair’s closing remarks and close of congress day 2

6:15

Networking Drinks & Party

last published: 14/Dec/17 14:05

 

DOWNLOAD DRAFT AGENDA

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

 

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

 

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

 

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071